Details for Patent: 11,806,428
Which drugs does patent 11,806,428 protect, and when does it expire?
Patent 11,806,428 protects RIVIVE and is included in one NDA.
This patent has fifty-three patent family members in thirty-seven countries.
Summary for Patent: 11,806,428
| Title: | Intranasal pharmaceutical dosage forms comprising naloxone |
| Abstract: | The present invention relates to an intranasal pharmaceutical dosage form comprising a dosing unit comprising naloxone or a pharmaceutically acceptable salt thereof in an amount of equivalent to ≥0.5 mg naloxone HCl dissolved in an application fluid of a volume of ≤250 μl. Furthermore, the present invention relates to such an intranasal pharmaceutical dosage form for use in the treatment of opioid overdosing and/or at least one symptom thereof. |
| Inventor(s): | John Strang, Alexander Oksche, Stephen Harris, Kevin Smith, Lucie Helene Jeanne Mottier |
| Assignee: | Harm Reduction Therapeutics Inc |
| Application Number: | US17/238,509 |
|
Patent Claim Types: see list of patent claims | Formulation; Compound; Device; Dosage form; |
Drugs Protected by US Patent 11,806,428
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Harm Reduction Therp | RIVIVE | naloxone hydrochloride | SPRAY, METERED;NASAL | 217722-001 | Jul 28, 2023 | OTC | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | Y | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 11,806,428
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Argentina | 086391 | ⤷ Start Trial | |||
| Austria | 16553 | ⤷ Start Trial | |||
| Australia | 2012257785 | ⤷ Start Trial | |||
| Australia | 2016204880 | ⤷ Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
